Who owns Verrica Pharmaceuticals Inc?
- Ticker: VRCA
- CUSIP Number: 92511w207
Tip: Access positions for across all investors
Analyze quarterly positions in Verrica Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Verrica Pharmaceuticals stock
Who bought or sold Verrica Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Caligan Partners | 924k | $5.7M | 0% | Jun 2026 |
|
| Cannell Capital | 784k | $4.8M | 14% | Jun 2026 |
|
| Affinity Asset Advisors | 707k | $4.3M | 0% | Jun 2026 |
|
| Velan Capital Investment Management | 472k | $2.9M | 0% | Jun 2026 |
|
| Armistice Capital | 426k | $2.6M | -18% | Jun 2026 |
|
| Boothbay Fund Management | 281k | $1.7M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 279k | $1.7M | 48% | Jun 2026 |
|
| Mariner Wealth Advisors | 207k | $1.3M | 744% | Jun 2026 |
|
| Geode Capital Management | 138k | $846k | -1% | Jun 2026 |
|
| BlackRock | 74k | $455k | 93% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 70k | $430k | 8% | Jun 2026 |
|
| Two Sigma Investments | 41k | $250k | -19% | Jun 2026 |
|
| State Street Corporation | 29k | $153k | 23% | Mar 2026 |
|
| Northern Trust | 27k | $165k | -15% | Jun 2026 |
|
| DAFNA Capital Management | 24k | $145k | -85% | Jun 2026 |
|
| Jane Street | 24k | $145k | -52% | Jun 2026 |
|
| Verdad Advisers | 23k | $141k | 91% | Jun 2026 |
|
| Morgan Stanley | 22k | $118k | 2% | Mar 2026 |
|
| Renaissance Technologies | 22k | $133k | -33% | Jun 2026 |
|
| Legacy Trust | 17k | $102k | -4% | Jun 2026 |
|
| Fifth Third Bancorp | 14k | $86k | 100% | Jun 2026 |
|
| Dimensional Fund Advisors | 14k | $85k | 100% | Jun 2026 |
|
| XTX Topco | 14k | $84k | 100% | Jun 2026 |
|
| Two Sigma Securities | 13k | $80k | 100% | Jun 2026 |
|
| Hrt Financial | 13k | $79k | 100% | Jun 2026 |
|
| Beck Mack & Oliver | 12k | $73k | 0% | Jun 2026 |
|
| UBS Group | 6.1k | $37k | 42% | Jun 2026 |
|
| Capital Analysts | 1.5k | $9.0k | 0% | Jun 2026 |
|
| Vanguard Global Advisers | 862.00 | $5.3k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 764.00 | $5.1k | -21% | Jun 2026 |
|
| Tower Research Capital | 614.00 | $3.8k | -28% | Jun 2026 |
|
| Salomon & Ludwin | 290.00 | $1.7k | 0% | Jun 2026 |
|
| Allied Private Wealth | 202.00 | $1.3k | 100% | Jun 2026 |
|
| New England Capital Financial Advisors | 200.00 | $1.2k | 0% | Jun 2026 |
|
| International Assets Investment Management | 175.00 | $1.0k | 0% | Jun 2026 |
|
| Fortitude Family Office | 127.00 | $776.998700 | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 110.00 | $673.002000 | 0% | Jun 2026 |
|
| Pnc Financial Services | 102.00 | $624.444000 | 0% | Jun 2026 |
|
| Barclays | 64.00 | $392.000000 | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 47.00 | $305.998200 | 100% | Jun 2026 |
|
| Ameritas Advisory Services | 30.00 | $183.999000 | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 26.00 | $178.001200 | 0% | Jun 2026 |
|
| Valley National Advisers | 25.00 | $153.000000 | 100% | Jun 2026 |
|
Who sold out of Verrica Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Mar 2026 | 141k | $743k |
| Stonepine Capital Management | Mar 2026 | 100k | $528k |
| Squarepoint Ops | Mar 2026 | 75k | $398k |
| Optiver Holding B.V. | Mar 2026 | 31.00 | $163.999300 |